Literature DB >> 23089541

Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites.

Victor J Del Brutto1, Oscar H Del Brutto, Elio Ochoa, Héctor H García.   

Abstract

BACKGROUND: A recent hypothesis suggested that in many cases cysticercal granulomas represent recently established Taenia solium metacestodes rapidly destroyed by the host's immune system. Here, we attempted to determine whether patients with cysticercal granulomas are younger than those with other forms of parenchymal brain cysticercosis.
METHODS: Series of 185 patients with single parenchymal brain cysticercus, classified according to the stage of the parasite at the moment of diagnosis in cysts without inflammation, cysts with inflammation, granular lesions, and calcifications. We correlated the age of the patients with the parasite evolutive stage.
RESULTS: Patients with cysticercus granulomas were significantly younger than those with vesicular cysts (17.7 ± 12.9 versus 36.8 ± 15.1 years, P<0.005) or calcifications (17.7 ± 12.9 versus 40.8 ± 19.7 years, P<0.0001). There was also a non-significant trend for patients with granulomas to be younger than those with coloidal cysts (17.7 ± 12.9 versus 26.7 ± 15.6 years, P = 0.367).
CONCLUSIONS: Results from this study argued against the classical hypothesis that granulomas are the end result from long-established vesicular cysts destroyed by the host's immune system. Vesicular (viable) cysticerci must be treated with cysticidal drugs as it is unlikely that they will be spontaneously destroyed.

Entities:  

Mesh:

Year:  2012        PMID: 23089541      PMCID: PMC5439517          DOI: 10.1179/1743132812Y.0000000100

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  10 in total

1.  Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú.

Authors:  R H Gilman; O H Del Brutto; H H García; M Martínez
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

2.  Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults.

Authors:  Brenda Sáenz; Matilde Ruíz-Garcia; Enedina Jiménez; Juan Hernández-Aguilar; Roberto Suastegui; Carlos Larralde; Edda Sciutto; Agnès Fleury
Journal:  Pediatr Infect Dis J       Date:  2006-09       Impact factor: 2.129

3.  Medical treatment of cysticercosis--ineffective.

Authors:  L D Kramer
Journal:  Arch Neurol       Date:  1995-01

4.  Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.

Authors:  H H García; O H Del Brutto
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

Review 5.  Neurocysticercosis: updated concepts about an old disease.

Authors:  Hector H Garcia; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

6.  Neurocysticercosis: unraveling the nature of the single cysticercal granuloma.

Authors:  H H García; A E Gonzalez; S Rodriguez; V C W Tsang; E J Pretell; I Gonzales; R H Gilman
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

7.  Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

Authors:  Agnès Fleury; Alain Dessein; Pierre Marie Preux; Michel Dumas; Graciela Tapia; Carlos Larralde; Edda Sciutto
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

8.  The association of host age and gender with inflammation around neurocysticercosis cysts.

Authors:  E A Kelvin; A Carpio; E Bagiella; D Leslie; P Leon; H Andrews; W A Hauser
Journal:  Ann Trop Med Parasitol       Date:  2009-09

Review 9.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

10.  Massive neurocysticercosis: encephalitic versus non-encephalitic.

Authors:  Oscar H Del Brutto; Xavier Campos
Journal:  Am J Trop Med Hyg       Date:  2012-09       Impact factor: 2.345

  10 in total
  3 in total

Review 1.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

2.  The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations.

Authors:  Annette Abraham; Javier A Bustos; Hélène Carabin; Robert de Meijere; Priyadarshi S Sahu; Vedantam Rajshekhar; Gagandeep Singh; A Clinton White; Peter L Chiodini; Sarah Gabriël; Mamoun Homeida; Theodore Nash; Bernard Ngowi; Xiao Nong Zhou; Christina Coyle; Hector H Garcia; Andrea S Winkler
Journal:  PLoS Negl Trop Dis       Date:  2021-03-31

3.  The many facets of disseminated parenchymal brain cysticercosis: A differential diagnosis with important therapeutic implications.

Authors:  Oscar H Del Brutto; Hector H Garcia
Journal:  PLoS Negl Trop Dis       Date:  2021-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.